UiPath Inc. faces heightened investor concern after weaker automation demand signals, and its stocks have been trading down by -3.37 percent
Key Takeaways
- UiPath shares fell between 16% and 17% after releasing its latest quarterly results, reflecting a sharply negative market reaction.
- Bank of America raised its UiPath price target from $13 to $15 but kept an Underperform rating after mixed fiscal Q2 results, citing uncertainty over whether AI will significantly accelerate ARR growth.
- RBC Capital lowered its UiPath price target from $17 to $15 while maintaining a Sector Perform rating, calling the stock a “show-me” story until results improve despite a strategic shift toward broader automation.
- UBS cut its UiPath price target from $19 to $15 and kept a Neutral rating, signaling reduced expectations for the stock’s upside.
- Truist reduced its UiPath price target from $17 to $14 while reiterating a Hold rating, aligning with a broader analyst consensus of Hold and an average price target of $16.66.
Live Update At 16:46:37 EDT: On Thursday, September 24, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -3.37%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
PATH has been on a rough ride since its post-earnings selloff. From a close near $18.67 on 2026/08/31, UiPath has slid to around $12.60 on 2026/09/24. That’s a steep drawdown, and traders feel it on the chart. The big gap down came right after the latest quarterly results, with PATH dropping from the mid-$18s into the mid-teens and then grinding lower.
Despite that, UiPath’s fundamentals are not falling apart. Recent quarterly revenue came in around $410.3M, with gross margin near 82.6%. That’s elite software territory. PATH also posted positive net income of roughly $36.1M and free cash flow around $29.3M, plus a strong balance sheet with minimal long-term debt and a current ratio of 2.4. The valuation, with a price-to-sales near 4x and a P/E around 19.8, looks far more “normal” than in past years.
More Breaking News
Intraday, PATH’s 5‑minute chart on 2026/09/24 shows tight consolidation around $12.60–$12.70, with failed pushes above $12.90 at the open. For short-term traders, that signals a stock digesting heavy selling, not yet breaking to a fresh trend. The next move from this base will matter.
Why Traders Are Watching PATH After The Selloff
PATH is in that classic “fallen favorite” spot that short-term traders love to stalk. UiPath shares dumped 16%–17% right after earnings and have not bounced with any real power since. Every pop into the $13s and $14s has been sold, pushing PATH back toward the low $12s. That tells you supply is still strong and longs are unloading into strength.
The news backdrop explains why. Bank of America nudged its UiPath target up from $13 to $15, but it still labels PATH Underperform and openly questions whether AI will truly accelerate annual recurring revenue. So even with better margins, the big theme — AI-driven growth — is on trial. When the market doubts the story, rallies tend to fade.
Then you have RBC Capital cutting its PATH target from $17 to $15 after Investor Day, calling the name a “show-me” story. Translation for traders: the Street wants proof, not promises. UBS joined in by slashing its UiPath target from $19 to $15, while Truist stepped down from $17 to $14. Across the board, key firms are dragging targets into the mid-teens and clustering around Hold or Neutral.
On top of that, RBC points out that application software names like UiPath are lagging hotter AI areas such as cyber, infrastructure, and data. Money is chasing picks-and-shovels AI plays, not necessarily automation platforms like PATH. For traders, that macro shift means bounces in UiPath may meet sector-wide selling pressure, creating both short setups and fade opportunities.
Conclusion
PATH now sits at the crossroads of a weak chart and a cautious Wall Street narrative. Traders see a stock that has been cut down from the high teens to the low $12s in less than a month, with a giant earnings gap overhead and price targets mostly clustered in the $14–$16 range. UiPath still has strong gross margins, positive earnings, and solid cash, but the market is saying that is not enough without faster, clearer ARR growth from AI.
For day traders and swing traders, this mix creates a textbook battleground. If PATH holds above recent lows and starts pushing through intraday resistance near $13 and then $14, you can get sharp relief rallies as shorts cover. If support cracks, the same bearish analyst tone that hit UiPath after earnings can fuel another leg down as late dip-buyers capitulate.
The key is to trade the price, not the hype around automation or AI. UiPath is a great case study in how a strong story can collide with unforgiving expectations. As Tim Sykes likes to say, “The market doesn’t care about your opinion, only about the price action — respect the trend, cut losses quickly, and let the chart guide you.” That mindset aligns with another core trading lesson: As millionaire penny stock trader and teacher Tim Sykes, says, “You must adapt to the market; the market will not adapt to you.”. For PATH, that means staying nimble, watching volume, and treating every move as a trade, not a belief system. This analysis is for educational and research purposes only, not investment advice.
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:







Leave a reply